Rebecca Hemsley

Becky is an experienced finance executive with extensive commercial experience. She has held senior finance and operations roles in VC backed, growing biotech and emerging technology businesses for many years. Becky was previously the SVP Finance & Operations for KaNDy Therapeutics, managing the successful transaction process for its sale to Bayer in September 2020. At Xention Ltd she was instrumental in agreeing their collaboration with Servier. Earlier experience includes working at PPD, the clinical research organisation, with responsibilities across EMEA, Asia and Australia.